FDGCX
Price
$20.44
Change
-$0.26 (-1.26%)
Updated
Jun 13 closing price
Net Assets
1.73B
VTSAX
Price
$142.91
Change
-$1.69 (-1.17%)
Updated
Jun 13 closing price
Net Assets
1.82T
Interact to see
Advertisement

FDGCX vs VTSAX

Header iconFDGCX vs VTSAX Comparison
Open Charts FDGCX vs VTSAXBanner chart's image
Fidelity Advisor Dividend Growth C
Price$20.44
Change-$0.26 (-1.26%)
VolumeN/A
Net Assets1.73B
Vanguard Total Stock Mkt Idx Adm
Price$142.91
Change-$1.69 (-1.17%)
VolumeN/A
Net Assets1.82T
FDGCX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FDGCX vs. VTSAX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDGCX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.82T vs. FDGCX (1.73B). VTSAX pays higher dividends than FDGCX: VTSAX (1.28) vs FDGCX (0.15). FDGCX was incepted earlier than VTSAX: FDGCX (26 years) vs VTSAX (25 years). FDGCX (1.85) is less costly to investors than VTSAX (0.04). FDGCX is a more actively managed with annual turnover of: 69.00 vs. VTSAX (2.00). FDGCX has a lower initial minimum investment than VTSAX: FDGCX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 10.07 vs. FDGCX (-0.72). VTSAX return over 5 years is better than : 91.40 vs. FDGCX (57.83).
FDGCXVTSAXFDGCX / VTSAX
Total Expense Ratio1.850.044,625%
Annual Report Gross Expense Ratio1.850.044,625%
Fund Existence26 years25 years-
Gain YTD3.1281.365229%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.73B1.82T0%
Annual Yield % from dividends0.151.2812%
Returns for 1 year-0.7210.07-7%
Returns for 3 years31.3257.6154%
Returns for 5 years57.8391.4063%
Returns for 10 years21.29179.5312%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP2.840.02
+0.71%
GT Biopharma
GMAB22.82-0.27
-1.17%
Genmab A/S ADS
FINW14.36-0.24
-1.64%
FinWise Bancorp
CENT34.21-1.31
-3.69%
Central Garden & Pet Company
CDLX1.51-0.09
-5.63%
Cardlytics